sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> biologics market

report

Biologics Market, by Products (Vaccines, Human Cells and Tissues, Gene Therapies, Xenotransplantation Products, Blood & Blood Product, Proteins & Allergenic Extracts ), Source Materials (Avian Cell Culture, Bacteria, Transgenic, Yeast, Insect Cell Culture & Humans ) and Applications (Cancer, Diabetes, Rheumatoid Arthritis, and Anemia ) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC114 October 2016 100+ FREE 10% CUSTOMIZATION

The global biologics market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, forecast for the next five years, key market players, and premium industry trends. The report also focuses on the key drivers, restraints, opportunities and the major challenges faced by the biologics market.

KEY BENEFITS OF THE REPORT

  • Deeper understanding of the strategies adopted by the key players in this market to stay competitive
  • Granular analysis about the growth map of the market during the next five years
  • Comprehensive analysis of the key market players and their market share

KEY PREMIUM INDUSTRY INSIGHTS

  • The increasing prevalence of the chronic diseases, expiration of the patents, the introduction of the favorable government initiatives, and the advancements in the diagnostic technologies are the major factors driving the growth of the biologics market.
  • Other factors such as an increase in the research and development activities by the major drug manufacturers and the favorable regulatory environment will boost the market growth for the biologics drugs.
  • The major restraints for the biologics market mainly include the environmental factors. ​To manufacture the biologics drugs, various environmental factors such as moisture, heat, and light need to be controlled; as these drugs are extremely complex in nature and also required a strict quality check. ​This process is expensive and complex and is not available in the developing nations, which may hinder the growth of the market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s biologics market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the biologics market by the following segments:

  • Biologics Market, by Product
    • Vaccine
    • Human Cells & Tissues
    • Gene Therapies
    • Xenotransplantation Products
    • Blood & Blood Product
    • Proteins
    • Allergenic Extracts
  • Biologics Market, by Source of Material
    • Avian Cell Culture
    • Bacteria
    • Transgenic
    • Yeast
    • Insect Cell Culture
    • Humans
  • Biologics Market, by Applications
    • Cancer
    • Diabetics
    • Rheumatoid Arthritis
    • Anemia

KEY MARKET PLAYERS

Key players in the biologics market include:

  • Pfizer, Inc
  • Becton , Dickinson & Company
  • Roche Diagnostics
  • Glaxo Smithland
  • Biological
  • AstraZeneca
  • Bayer AG
  • Merck KGaA
  • Novartis AG
  • H. Lund beck A/S
  • Enzyme Corporation
  • Smiths Medical
  • Unilife Corporation
  • Retractable Technologies, Inc.
  • Terumo Corporation

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

Biologics Market

TRENDING RELATED REPORT

Home Healthcare Market, by Products (Patient Diagnosis/Treatment Devices, Assistive Technology Based Devices and Enteral Feeding Devices), Services (Rehabilitation, Home Respiratory Therapy, Home Infusion Therapy, Telehealth and Unskilled Home Healthcare Services) - Global Revenue, Trends, Growth, Share, Size & Forecast to 2021


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
    4. Assumptions
    5. Limitations
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Patent Analysis
    3. Regulatory Analysis
    4. Reimbursement Landscape
  5. BIOLOGICS MARKET, BY PRODUCT
    1. Segment Share
    2. By Product
      1. Vaccine
      2. Human Cells & Tissues
      3. Gene Therapies
      4. Xenotransplantation Products
      5. Blood & Blood Product
      6. Proteins
      7. Allergenic Extracts
  6. BIOLOGICS MARKET, BY SOURCE OF MATERIAL
    1. Segment Share
    2. By Source of Material
      1. Avian Cell Culture
      2. Bacteria
      3. Transgenic
      4. Yeast
      5. Insect Cell Culture
      6. Humans
  7. BIOLOGICS MARKET, BY APPLICATIONS
    1. Segment Share
    2. By Applications
      1. Cancer
      2. Diabetics
      3. Rheumatoid Arthritis
      4. Anemia
  8. BIOLOGICS MARKET, BY GEOGRAPHY
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Product
      3. By Source of Material
      4. By Applications
      5. By Connectivity Service
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K
        4. Rest of Europe
      2. By Product
      3. By Source of Material
      4. By Applications
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Product
      3. By Source of Material
      4. By Applications
    4. Rest of the World
      1. By Country
        1. Latin America
        2. Middle East & Africa
      2. By Product
      3. By Source of Material
      4. By Applications
  9. COMPETITIVE LANDSCAPE
    1. Market Share Analysis
    2. Key Innovators
  10. KEY MARKET PLAYERS
    1. Pfizer, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. Becton, Dickinson and Company
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. F. Hoffmann-La Roche Ltd.
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. GlaxoSmithKline Plc
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. AstraZeneca
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Bayer AG
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. Novartis AG
      1. Overview
      2. Key Strategies
      3. Key Developments
    8. Merck KGaA
      1. Overview
      2. Key Strategies
      3. Key Developments
    9. H. Lundbeck A/S
      1. Overview
      2. Key Strategies
      3. Key Developments
    10. Genzyme Corporation
      1. Overview
      2. Key Strategies
      3. Key Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us